(Total Views: 415)
Posted On: 10/15/2020 11:59:40 PM
Post# of 154975
Re: nmbr1stckpckr #61404
nbmr1,
You're right on all counts (fixed my typo, thanks).
I have little faith in FDA. After recent events, perhaps that will be a reversion to expected diligent adherence to science. Cytodyn, as best I can tell, has faithfully followed the rules.
As others have pointed, this seems to be an endeavor of attrition. Leronlimab remains standing while so many others have fallen along the way.
As I posted earlier, my faith in leronlimab is steadfast. Regulatory hurdles and the ability of Cytodyn to navigate the minefield is my concern. The PR leads me to believe that Cytodyn is marching forward.
UK is waiting on the same interim results and Philippines now in play.
All good IMO
You're right on all counts (fixed my typo, thanks).
I have little faith in FDA. After recent events, perhaps that will be a reversion to expected diligent adherence to science. Cytodyn, as best I can tell, has faithfully followed the rules.
As others have pointed, this seems to be an endeavor of attrition. Leronlimab remains standing while so many others have fallen along the way.
As I posted earlier, my faith in leronlimab is steadfast. Regulatory hurdles and the ability of Cytodyn to navigate the minefield is my concern. The PR leads me to believe that Cytodyn is marching forward.
UK is waiting on the same interim results and Philippines now in play.
All good IMO
(3)
(0)
